
Sino Biological Inc. — Investor Relations & Filings
Sino Biological Inc. is a global provider of biological reagents and contract research services, specializing in recombinant protein and antibody technologies. The company maintains an extensive catalog of off-the-shelf products, including thousands of recombinant proteins, cytokines, viral antigens, and monoclonal antibodies. These resources support diverse applications in drug discovery, diagnostic development, and basic life science research. Beyond its product portfolio, the company offers comprehensive CRO services such as custom protein expression, antibody development, and biological testing. Utilizing high-throughput mammalian and insect cell expression platforms, Sino Biological provides scalable solutions for the pharmaceutical and biotechnology sectors. The organization is particularly noted for its rapid reagent development in response to emerging infectious diseases and its integrated approach to supporting the global research community.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于注销回购股份减少注册资本暨通知债权人的公告 | 2025-05-09 | Chinese | |
| 2024年年度股东大会决议公告 | 2025-05-09 | Chinese | |
| 中信证券股份有限公司关于北京义翘神州科技股份有限公司持续督导保荐总结报告书 | 2025-04-29 | Chinese | |
| 中信证券股份有限公司关于北京义翘神州科技股份有限公司2024年度跟踪报告 | 2025-04-29 | Chinese | |
| 中信证券股份有限公司关于北京义翘神州科技股份有限公司2024年度持续督导培训情况报告 | 2025-04-29 | Chinese | |
| 中信证券股份有限公司关于北京义翘神州科技股份有限公司2024年度持续督导工作现场检查报告 | 2025-04-29 | Chinese |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 44561404 | 关于注销回购股份减少注册资本暨通知债权人的公告 | 2025-05-09 | Chinese | ||
| 44561390 | 2024年年度股东大会决议公告 | 2025-05-09 | Chinese | ||
| 44561386 | 中信证券股份有限公司关于北京义翘神州科技股份有限公司持续督导保荐总结报告书 | 2025-04-29 | Chinese | ||
| 44561383 | 中信证券股份有限公司关于北京义翘神州科技股份有限公司2024年度跟踪报告 | 2025-04-29 | Chinese | ||
| 44561373 | 中信证券股份有限公司关于北京义翘神州科技股份有限公司2024年度持续督导培训情况报告 | 2025-04-29 | Chinese | ||
| 44561365 | 中信证券股份有限公司关于北京义翘神州科技股份有限公司2024年度持续督导工作现场检查报告 | 2025-04-29 | Chinese | ||
| 44561355 | 2025年一季度报告 | 2025-04-23 | Chinese | ||
| 44561337 | 董事会决议公告 | 2025-04-18 | Chinese | ||
| 44561326 | 关于续聘2025年度审计机构的公告 | 2025-04-18 | Chinese | ||
| 44561318 | 2024年度内部控制自我评价报告 | 2025-04-18 | Chinese | ||
| 44561303 | 关于2025年度日常关联交易预计的公告 | 2025-04-18 | Chinese | ||
| 44561301 | 关于部分募投项目不同实施主体投资金额调整及延期的公告 | 2025-04-18 | Chinese | ||
| 44561287 | 关于使用部分闲置自有资金进行现金管理的公告 | 2025-04-18 | Chinese | ||
| 44561277 | 董事会对独董独立性评估的专项意见 | 2025-04-18 | Chinese | ||
| 44561265 | 中信证券股份有限公司关于北京义翘神州科技股份有限公司2024年度募集资金存放与使用情况专项核查报告 | 2025-04-18 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
Sino Biological Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56004/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56004 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56004 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56004 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56004}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Sino Biological Inc. (id: 56004)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.